Diakonie-Klinikum Schwaebisch Hall gGmbH
- Address
- lock Available on a paid plan
Diakonie-Klinikum Schwaebisch Hall gGmbH - Gynecologic Oncology Research Center
Diakonie-Klinikum Schwaebisch Hall gGmbH is a distinguished medical institution participating in advanced oncological research, with particular expertise in gynecologic malignancies. The center demonstrates specialization in precision medicine approaches to endometrial cancer treatment, focusing on molecular characterization to guide therapeutic strategies.
- Molecular-based adjuvant therapy in high-risk endometrial cancer
- Mismatch repair deficient (MMRd) endometrial cancer treatment optimization
- Advanced surgical oncology with comprehensive staging procedures
The center actively contributes to the RAINBO platform trials (TRANSPORTEC), investigating recurrence-free survival outcomes in patients with mismatch repair deficient high-risk endometrial cancer (MMRd HREC). Their research encompasses all histological subtypes including carcinosarcoma, focusing on Stage IB/II with lymphovascular space invasion (LVSI) through Stage IIIA-C disease. The facility provides comprehensive surgical management including hysterectomy, bilateral salpingo-oophorectomy, and lymph node assessment, with curative intent for patients without residual disease or distant metastases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 5 therapeutic areas and 15 of 48 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 48 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
lock +9 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diakonie-Klinikum Schwaebisch Hall gGmbH
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase II randomized, open label non-inferiority study of NiraParib maintenance after 3 vs. 6 cycles of platinum-based chemotherapy in completeLy debUlked advanced HRDpositive high-grade ovarian cancer patientS in first line therapy | Nord-Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V. | Phase II | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 48 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lenalidomide | 4 | Unknown | 2018-10-18 | 2026-07-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.